Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue 1.4 Market Analysis by Type 1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 HEPtune® Technology 1.4.3 Intravail® Technology 1.4.4 RapidMist™ 1.4.5 TheraKine Technology 1.4.6 Arestat™ Technology 1.4.7 DelSiTech™ Silica Matrix 1.4.8 ImSus® Technology 1.4.9 PLEX™ Technology 1.4.10 ENHANZE® Technology 1.5 Market by Application 1.5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2026 1.5.2 Delivery of Protein 1.5.3 Delivery of Nucleic Acids 1.5.4 Delivery Antibody 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Perspective (2015-2026) 2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions 2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Share by Regions (2015-2020) 2.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Growth Strategy 2.3.6 Primary Interviews with Key Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Market Size 3.1.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue (2015-2020) 3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Players (2015-2020) 3.1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio 3.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2019 3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served 3.4 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service 3.5 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Type (2015-2020) 4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2021-2026) 5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Breakdown Data by Application (2015-2026) 5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 5.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in North America (2019-2020) 6.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 6.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 7 Europe 7.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 7.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Europe (2019-2020) 7.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 7.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 8 China 8.1 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 8.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in China (2019-2020) 8.3 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 8.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 9 Japan 9.1 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 9.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Japan (2019-2020) 9.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 9.4 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 10.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 10.4 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 11 India 11.1 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in India (2019-2020) 11.3 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 11.4 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2015-2020) 12.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Central & South America (2019-2020) 12.3 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) 12.4 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Aphios 13.1.1 Aphios Company Details 13.1.2 Aphios Business Overview and Its Total Revenue 13.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020)) 13.1.5 Aphios Recent Development 13.2 Arbutus Biopharma 13.2.1 Arbutus Biopharma Company Details 13.2.2 Arbutus Biopharma Business Overview and Its Total Revenue 13.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) 13.2.5 Arbutus Biopharma Recent Development 13.3 Camurus 13.3.1 Camurus Company Details 13.3.2 Camurus Business Overview and Its Total Revenue 13.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) 13.3.5 Camurus Recent Development 13.4 ConjuChem 13.4.1 ConjuChem Company Details 13.4.2 ConjuChem Business Overview and Its Total Revenue 13.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) 13.4.5 ConjuChem Recent Development 13.5 InnoCore Pharmaceuticals 13.5.1 InnoCore Pharmaceuticals Company Details 13.5.2 InnoCore Pharmaceuticals Business Overview and Its Total Revenue 13.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) 13.5.5 InnoCore Pharmaceuticals Recent Development 13.6 LATITUDE Pharmaceuticals 13.6.1 LATITUDE Pharmaceuticals Company Details 13.6.2 LATITUDE Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction 13.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) 13.6.5 LATITUDE Pharmaceuticals Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Market Segments Table 2. Key Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Table 3. Ranking of Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of HEPtune® Technology Table 6. Key Players of Intravail® Technology Table 7. Key Players of RapidMist™ Table 8. Key Players of TheraKine Technology Table 9. Key Players of Arestat™ Technology Table 10. Key Players of DelSiTech™ Silica Matrix Table 11. Key Players of ImSus® Technology Table 12. Key Players of PLEX™ Technology Table 13. Key Players of ENHANZE® Technology Table 14. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 15. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (US$ Million): 2020 VS 2026 Table 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2015-2020) (US$ Million) Table 17. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2015-2020) Table 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 19. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2021-2026) Table 20. Market Top Trends Table 21. Key Drivers: Impact Analysis Table 22. Key Challenges Table 23. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Growth Strategy Table 24. Main Points Interviewed from Key Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players Table 25. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Players (2015-2020) (Million US$) Table 26. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players (2015-2020) Table 27. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2019) Table 28. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Players Market Concentration Ratio (CR5 and HHI) Table 29. Key Players Headquarters and Area Served Table 30. Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service Table 31. Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Table 32. Mergers & Acquisitions, Expansion Plans Table 33. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 34. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Type (2015-2020) Table 35. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2021-2026) Table 36. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2015-2020) Table 37. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 38. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2021-2026) Table 39. North America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 40. North America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 41. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 42. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 43. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 44. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 45. Europe Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 46. Europe Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 47. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 48. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 49. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 50. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 51. China Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 52. China Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 53. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 54. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 55. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 56. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 57. Japan Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 58. Japan Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 59. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 60. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 61. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 62. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 63. Southeast Asia Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 64. Southeast Asia Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 65. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 66. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 67. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 68. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 69. India Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 70. India Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 71. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 72. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 73. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 74. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 75. Central & South America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (2019-2020) (Million US$) Table 76. Central & South America Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share (2019-2020) Table 77. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2015-2020) (Million US$) Table 78. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2015-2020) Table 79. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2015-2020) (Million US$) Table 80. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2015-2020) Table 81. Aphios Company Details Table 82. Aphios Business Overview Table 83. Aphios Product Table 84. Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 85. Aphios Recent Development Table 86. Arbutus Biopharma Company Details Table 87. Arbutus Biopharma Business Overview Table 88. Arbutus Biopharma Product Table 89. Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 90. Arbutus Biopharma Recent Development Table 91. Camurus Company Details Table 92. Camurus Business Overview Table 93. Camurus Product Table 94. Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 95. Camurus Recent Development Table 96. ConjuChem Company Details Table 97. ConjuChem Business Overview Table 98. ConjuChem Product Table 99. ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 100. ConjuChem Recent Development Table 101. InnoCore Pharmaceuticals Company Details Table 102. InnoCore Pharmaceuticals Business Overview Table 103. InnoCore Pharmaceuticals Product Table 104. InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 105. InnoCore Pharmaceuticals Recent Development Table 106. LATITUDE Pharmaceuticals Company Details Table 107. LATITUDE Pharmaceuticals Business Overview Table 108. LATITUDE Pharmaceuticals Product Table 109. LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) (Million US$) Table 110. LATITUDE Pharmaceuticals Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type: 2020 VS 2026 Figure 2. HEPtune® Technology Features Figure 3. Intravail® Technology Features Figure 4. RapidMist™ Features Figure 5. TheraKine Technology Features Figure 6. Arestat™ Technology Features Figure 7. DelSiTech™ Silica Matrix Features Figure 8. ImSus® Technology Features Figure 9. PLEX™ Technology Features Figure 10. ENHANZE® Technology Features Figure 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2026 Figure 12. Delivery of Protein Case Studies Figure 13. Delivery of Nucleic Acids Case Studies Figure 14. Delivery Antibody Case Studies Figure 15. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Report Years Considered Figure 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth 2015-2026 (US$ Million) Figure 17. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions: 2020 VS 2026 Figure 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2021-2026) Figure 19. Porter's Five Forces Analysis Figure 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players in 2019 Figure 21. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2019 Figure 22. The Top 10 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2019 Figure 23. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 25. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 28. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2015-2020) (Million US$) Figure 30. Aphios Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Aphios Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 32. Arbutus Biopharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Arbutus Biopharma Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 34. Camurus Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Camurus Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 36. ConjuChem Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. ConjuChem Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 38. InnoCore Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. InnoCore Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 40. LATITUDE Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. LATITUDE Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2015-2020) Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

Aphios Arbutus Biopharma Camurus ConjuChem InnoCore Pharmaceuticals LATITUDE Pharmaceuticals